Shayani Rad, Maryam
Moohebati, Mohsen
MohammadEbrahimi, Shahab
Motamedshariaty, Vahideh Sadat
Mohajeri, Seyed Ahmad https://orcid.org/0000-0002-7907-9625
Funding for this research was provided by:
Mashhad University of Medical Sciences (941237)
Article History
Received: 5 March 2022
Accepted: 26 March 2022
First Online: 10 May 2022
Declarations
:
: We declare there is no conflict of interest related to this study and there was no financial support that influence its outcome.
: The study is in compliance with the regulations of Iran and approved by an independent ethics committee of Mashhad University of Medical Sciences, Mashhad, Iran (ethics committee reference number and approval date: IR.MUMS.REC.1394.705, 2016-02-27).
: Details and procedures of the study were completely explained to patients through an interview, consent to participate was obtained before the start of study treatment.
: Consent for publication gives my consent for the publication of identifiable details, which can include details within the text to be published in Inflammopharmacology.